BERKELEY HEIGHTS, N.J., Aug. 10, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders will announce second quarter 2012 financial results on Tuesday, August 14, 2012. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
|Conference call information:|
|US/Canada call: (877) 493-9121/ international call: (973) 582-2750|
|US/Canada archive: (800) 585-8367 / international archive: (404) 537-3406|
|Code for live and archived conference call is 15123322|
CONTACT: Contact for Cyclacel Pharmaceuticals, Inc. Investors/Media: Corey Sohmer, (908) 517-7330, email@example.com